Latest News & Features
Big Pharma
European law firm Fieldfisher has strengthened its intellectual property expertise with the appointment of three team members in Milan, Italy. 20 October 2016
Americas
The US Food and Drug Administration has awarded 21 new clinical trial research grants totalling more than $23 million in order to boost the development of products for patients with rare diseases. 20 October 2016
Asia
Indian pharmaceutical company Sun Pharma and the International Centre for Genetic Engineering and Biotechnology have entered into an exclusive collaboration to develop a novel dengue vaccine for India and global markets. 19 October 2016
Americas
The US Court of Appeals for the Federal Circuit has affirmed the Patent Trial and Appeal Board’s (PTAB) decision to reject a patent application centring on an influenza drug. 19 October 2016
Americas
Law firm Goodwin has hired Scott Lassman to join its Washington, DC office as a partner in the life sciences practice. 19 October 2016
Americas
Japanese pharmaceutical company Astellas has filed a complaint against another Japanese company, Sawai Pharmaceutical, for allegedly infringing its patents centring on the drug Myrbetriq. 18 October 2016
Americas
Pfizer announced yesterday that it will launch a biosimilar of one of Johnson & Johnson’s (J&J) best-selling drugs, Remicade (infliximab), which brought in a total of $9.2 billion in revenue last year. 18 October 2016
Americas
David Manspeizer and Greg Chopskie have joined Morrison & Foerster’s intellectual property litigation practice group in its New York and Washington offices respectively. 18 October 2016
Big Pharma
The Court of Justice of the European Union has ruled that certain legislation on supplementary protection certificates applies to SPCs granted by a country before it has joined the EU. 17 October 2016
Americas
The US Court of Appeals for the Federal Circuit has affirmed a district court’s patent ruling in favour of global pharma company Endo and Scotland-based Strakan International in a case against Actavis. 17 October 2016